The purpose of this survey is to provide the Canadian Cancer Survivor Network (CCSN) with insights and perspectives about the use of denosumab (Xgeva) for the prevention of skeletal-related events due to bone metastases from solid tumours. The information gathered from this survey will be used in order to prepare a patient evidence submission to the CADTH Common Drug Review. Please note that your personal
Tag: Metastatic Prostate Cancer
Giving a Voice to Men with Metastatic Prostate Cancer: Awareness Reception at Queen’s Park on September 27, 2012
TORONTO, September 20, 2012 – In recent years, prostate cancer awareness and research has made significant headway with global educational campaigns focused on prevention and survivorship; however, less attention has been given to prostate cancer in the advanced stages – for men whose cancer has spread, or metastasized – and who are running out of time. September is Prostate Cancer Awareness Month and on Thursday, September 27, the